OTCMKTS:EMHTF Emerald Health Therapeutics (EMHTF) Stock Price, News & Analysis → Watch this FREE trading tutorial while it’s still available (From InvestorPlace) (Ad) Free EMHTF Stock Alerts $0.04 +0.01 (+55.17%) (As of 11/11/2022) Add Compare Share Share Today's Range$0.03▼$0.0450-Day Range$0.04▼$0.0452-Week Range$0.02▼$0.09Volume1.05 million shsAverage Volume116,962 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Emerald Health Therapeutics alerts: Email Address Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story About Emerald Health Therapeutics Stock (OTCMKTS:EMHTF)Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.Read More EMHTF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EMHTF Stock News HeadlinesFebruary 16, 2024 | npr.orgShotsOctober 6, 2023 | health.usnews.comEmerald D. RobinsonMay 7, 2024 | DTI (Ad)Is Tesla going out of business?Goldman Sachs estimates that this new “Future Fuel” will unleash an $11.7 trillion wave of wealth over the coming decade. That’s 10 TIMES BIGGER than the electric vehicle market. January 12, 2023 | finance.yahoo.comEmerald Health Pharmaceuticals Receives Safety Review Committee Approval to Proceed to Final Cohorts of EHP-101 Phase 2a Systemic Sclerosis TrialNovember 9, 2022 | finance.yahoo.comIIROC Trading Halt - EMHNovember 7, 2022 | finance.yahoo.comEmerald Health Therapeutics and Skye Bioscience Announce Intended Closing Date of Plan of ArrangementSeptember 2, 2022 | seekingalpha.comEmerald Health Therapeutics Q2 GAAP EPS of -C$0.01, revenue of C$1.28MAugust 23, 2022 | finance.yahoo.comHYTN Awarded Medical Cannabis Sales Licence Increasing Opportunities at Kelowna FacilityMay 7, 2024 | DTI (Ad)Is Tesla going out of business?Goldman Sachs estimates that this new “Future Fuel” will unleash an $11.7 trillion wave of wealth over the coming decade. That’s 10 TIMES BIGGER than the electric vehicle market. August 12, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Restates Q1 Financial Statements to Meet PCAOB StandardAugust 12, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Provides Update on and Additional Background to Transaction with Skye BioscienceJuly 13, 2022 | finanznachrichten.deEmerald Health Therapeutics, Inc.: Emerald Health Therapeutics Announces Revocation of Management Cease Trade OrderJuly 11, 2022 | nz.finance.yahoo.comEMERALD HEALTH SCIENCES INC.June 3, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Provides Second Bi-Weekly MCTO Status UpdateMay 12, 2022 | finance.yahoo.comEmerald Health Therapeutics Signs Arrangement Agreement with Skye BioscienceMay 6, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Transfers US Listing to OTCQBApril 28, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Applies for Management Cease Trade OrderMarch 17, 2022 | msn.comHYTN Innovations To Accept Cannabis Orders Directly From Provinces & TerritoriesMarch 17, 2022 | finance.yahoo.comHYTN Begins Accepting Orders Directly from Provinces and TerritoriesFebruary 22, 2022 | benzinga.comHYTN Innovations Receives Health Canada's Approval To Sell CannabisFebruary 22, 2022 | finance.yahoo.comHYTN Innovations Awarded Approval for the Sale of Cannabis to Provincially and Territorially Authorized RetailersJanuary 11, 2022 | nz.finance.yahoo.comEmerald Health Pharmaceuticals Receives IND Clearance to Begin Phase 2 Clinical Trial of EHP-101 for Relapsing Forms of Multiple SclerosisJanuary 11, 2022 | finance.yahoo.comEmerald Health Therapeutics Sells Patents to FlowerPodJanuary 4, 2022 | benzinga.comEmerald Holdings Buys MJBiz For $120M, Signaling Widespread Acceptance Of Booming Cannabis IndustryDecember 5, 2021 | stockhouse.comEmerald Health Therapeutics Inc EMHTFDecember 1, 2021 | benzinga.comRiaz BandaliOctober 28, 2021 | benzinga.comEmerald Health's Partner, Flower Pod, Launches Unique Dose-Controlled Cannabis VaporizerSee More Headlines Receive EMHTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorOils/Energy Industry Oil & Gas Production Sub-IndustryN/A Current SymbolOTCMKTS:EMHTF CUSIPN/A CIK1768225 Webwww.emerald.care Phone(800) 757-3536FaxN/AEmployees110Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Mohammed JiwanChief Operating OfficerMr. Bernie HertelVP of Fin. and CommunicationsMs. Rebecca WongSr. VP of Quality & Regulatory AffairsKey CompetitorsGASFRAC Energy ServicesOTCMKTS:GSFVFLeucrotta ExplorationOTCMKTS:LCRTFSeven Generations EnergyOTCMKTS:SVRGFSpyglass ResourcesOTCMKTS:PACEFTORC Oil & GasOTCMKTS:VREYFView All Competitors EMHTF Stock Analysis - Frequently Asked Questions How have EMHTF shares performed in 2024? Emerald Health Therapeutics' stock was trading at $0.0405 at the start of the year. Since then, EMHTF stock has increased by 0.0% and is now trading at $0.0405. View the best growth stocks for 2024 here. How do I buy shares of Emerald Health Therapeutics? Shares of EMHTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EMHTF) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emerald Health Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
